galantamine and Anoxia-Ischemia, Brain
galantamine has been researched along with Anoxia-Ischemia, Brain in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Duran-Carabali, LE; Figueiró, F; Gonçalves, CA; Kolling, J; Konrath, EL; Netto, CA; Nicola, F; Odorcyk, FK; Vizuete, A; Wyse, ATS | 1 |
| Furukawa, S; Sameshima, H; Yang, L | 1 |
Other Studies
2 other study(ies) available for galantamine and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Galantamine administration reduces reactive astrogliosis and upregulates the anti-oxidant enzyme catalase in rats submitted to neonatal hypoxia ischemia.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Catalase; Cholinesterase Inhibitors; Drug Administration Schedule; Female; Fluoresceins; Galantamine; Glial Fibrillary Acidic Protein; Gliosis; Hypoxia-Ischemia, Brain; Male; Rats; Rats, Wistar; Reactive Nitrogen Species; S100 Calcium Binding Protein beta Subunit; Superoxide Dismutase; Up-Regulation | 2017 |
Galantamine, an acetylcholinesterase inhibitor, reduces brain damage induced by hypoxia-ischemia in newborn rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Brain Injuries; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Galantamine; Hypoxia-Ischemia, Brain; Interleukin-1beta; Microglia; Rats | 2014 |